Medmira Inc. Stock
Price
Target price
€0.058
€0.058
3.600%
0.002
3.600%
-
09.05.24 / Stuttgart Stock Exchange
WKN: 932414 / Name: MedMira / Stock / Healthcare Equipment & Supplies / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Medmira Inc. Stock
A very strong showing by Medmira Inc. today, with an increase of €0.002 (3.600%) compared to yesterday's price.
Pros and Cons of Medmira Inc. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medmira Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medmira Inc. | 3.600% | 5.505% | 17.347% | -6.504% | -11.538% | - | - |
| Theralase Technologies Inc | - | 3.141% | -7.944% | -36.039% | -5.288% | -25.940% | -64.607% |
| InVivo Therapeutics Holdings | -4.790% | 2.581% | 0.000% | -75.195% | -53.779% | -99.933% | -99.961% |
| Star Equity Holdings Inc. | 2.310% | 5.988% | 5.988% | 14.194% | -5.851% | -61.853% | -85.076% |
News
MedMira Announces the Hire of Vice President of Business Development
Halifax, Nova Scotia, 30 April, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to announce the expansion of their commercialisation team by welcoming Ms. Rene Bell to the
MedMira gibt Einstellung eines Vizepräsidenten für Geschäftsentwicklung bekannt
Halifax, Nova Scotia, 30 April, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to announce the expansion of their commercialisation team by welcoming Ms. Rene Bell to the
MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System
Halifax, Nova Scotia, March 13, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a Canadian patent (number 2,949,634) for its new innovative and quantitative test